The startup develops intravenous line infusion monitoring services that utilize flow management automation technology and flow sensors to enhance patient safety in neonatal and pediatric intensive care. By improving the accuracy of fluid balance, the company reduces the workload on nurses and minimizes the risk of respiratory disorders in vulnerable patients.
Funding
$860K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In neonatal and pediatric intensive care units (NICUs and PICUs), intravenous (IV) infusion therapy, a primary method of drug delivery, often suffers from flow rate errors in over 60% of cases due to factors like occlusions and multi-infusion dynamics. Current IV systems struggle to detect flow changes, especially at low infusion rates (< 2 mL/hr), leading to potential over or under dosage of medication. These inaccuracies can result in serious clinical consequences for vulnerable patients, including neurodevelopmental impairment and increased mortality rates.
Solution
Sencilia addresses the critical need for accurate IV infusion monitoring with Rely-V™, an innovative IV flow monitoring technology designed for neonatal and pediatric patients. Rely-V™ employs a microelectromechanical systems (MEMS) sensor to provide real-time dosage insights, particularly at low flow rates (< 5 mL/hr) common in NICUs. The system integrates seamlessly into existing IV setups, offering clinicians continuous remote monitoring and immediate wireless alerts for any abnormal flow rates, reducing response times and minimizing the risk of adverse drug events. Rely-V™ ensures contamination-free drug monitoring with a reusable, non-contact sensor, promoting patient safety and improving overall outcomes in intensive care settings.
Target Audience
The primary target audience includes clinicians in neonatal and pediatric intensive care units (NICUs and PICUs) seeking to improve the safety and accuracy of IV infusion therapy for vulnerable patients.
Features
- Microelectromechanical systems (MEMS) sensor technology for accurate measurements at low flow rates (< 5 mL/hr)
- Non-contact, reusable sensor design to prevent fluid contamination
- Wireless connectivity for instant alerts on flow rate abnormalities, reducing response time by up to one hour
- Continuous remote monitoring of multi-infusion status, providing real-time data to nurses and doctors
- Seamless integration with existing IV tubes, requiring no changes to clinical workflows
- Companion display device with mobile app integration for convenient data access
- Designed to measure flow rate near the vascular access site for accurate drug flow readings